# Travera, Inc.: Form D filings

Travera, Inc., a biotechnology company in Medford, MA, filed 5 Form D notices with the SEC between 2018 and 2021. The latest, on July 14, 2021, reports $4 million sold of a $4 million offering to 2 investors.

Find out what Travera, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Travera%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Travera%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftravera-inc-1732756)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Travera%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Travera%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftravera-inc-1732756)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 200 BOSTON AVENUE, SUITE 1500, Medford, MA, 02155
- Phone: (650) 576-7738
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1732756

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 14, 2021 | New notice | $4,000,000 | $4,000,000 | $0 | 2 | Jul 2, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1732756/000173275621000005/0001732756-21-000005-index.htm) |
| Apr 20, 2021 | Amendment | $8,850,000 | $8,409,856 | $440,144 | 20 | Jun 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1732756/000173275621000002/0001732756-21-000002-index.htm) |
| Jul 8, 2019 | Amendment | $7,850,000 | $6,709,856 | $1,140,144 | 18 | Jun 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1732756/000173275619000001/0001732756-19-000001-index.htm) |
| Jun 19, 2018 | New notice | $4,850,000 | $4,575,000 | $275,000 | 17 | Jun 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1732756/000173275618000002/0001732756-18-000002-index.htm) |
| Feb 26, 2018 | New notice | $850,000 | $850,000 | $0 | 4 | Feb 16, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1732756/000173275618000001/0001732756-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Clifford A. Reid | Executive Officer, Director |  |
| Laurence Robert Johnson | Director |  |
| David Robert Margulies | Director |  |
| Patrick Robert Zhang | Director |  |

## Other biotechnology companies in Massachusetts that filed recently

- [Zai Lab Ltd](https://specstream.ai/data/form-d/company/zai-lab-ltd-1704292) $249.9 million · Nov 9, 2026
- [AI3 Bio, Inc.](https://specstream.ai/data/form-d/company/ai3-bio-inc-2019875) offering · Nov 4, 2026
- [Tru Singular Health, Inc.](https://specstream.ai/data/form-d/company/tru-singular-health-inc-2158834) $1 million · Oct 30, 2026
- [511 Therapeutics, Inc.](https://specstream.ai/data/form-d/company/511-therapeutics-inc-1946264) $500,000 · Oct 30, 2026
- [Elucid Bioimaging Inc.](https://specstream.ai/data/form-d/company/elucid-bioimaging-inc-1585931) $56.2 million · Oct 27, 2026
- [OrthoIQ, Inc.](https://specstream.ai/data/form-d/company/orthoiq-inc-2154488) $1.1 million · Oct 23, 2026
- [LeanBio Therapeutics, Inc.](https://specstream.ai/data/form-d/company/leanbio-therapeutics-inc-2160802) offering · Oct 22, 2026
- [Quiver Holdings Inc.](https://specstream.ai/data/form-d/company/quiver-holdings-inc-2160800) $3 million · Oct 21, 2026
- [Axelyf, Inc.](https://specstream.ai/data/form-d/company/axelyf-inc-2078406) $2.6 million · Oct 13, 2026
- [BIOVENTRIX, INC.](https://specstream.ai/data/form-d/company/bioventrix-inc-1283259) $1.2 million · Oct 8, 2026
- [Opus KSD, Inc.](https://specstream.ai/data/form-d/company/opus-ksd-inc-1668934) $680,801 · Oct 1, 2026
- [Xact Bio, Inc.](https://specstream.ai/data/form-d/company/xact-bio-inc-2157427) $10 million · Sep 28, 2026
- [Way Biosolutions, Inc.](https://specstream.ai/data/form-d/company/way-biosolutions-inc-2155613) $2 million · Sep 25, 2026
- [AutoIVF, Inc.](https://specstream.ai/data/form-d/company/autoivf-inc-1807161) $1.5 million · Sep 25, 2026
- [Typewriter Therapeutics, Inc.](https://specstream.ai/data/form-d/company/typewriter-therapeutics-inc-2156390) $56.3 million · Sep 21, 2026

[Every Form D from the week of Jul 12, 2021](https://specstream.ai/data/form-d/week/2021-07-12) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Travera, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).